Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 19:11:122-142.
doi: 10.2174/1874364101711010122. eCollection 2017.

Many Faces of Renin-angiotensin System - Focus on Eye

Affiliations
Review

Many Faces of Renin-angiotensin System - Focus on Eye

Mervi Holappa et al. Open Ophthalmol J. .

Abstract

The renin-angiotensin system (RAS), that is known for its role in the regulation of blood pressure as well as in fluid and electrolyte homeostasis, comprises dozens of angiotensin peptides and peptidases and at least six receptors. Six central components constitute the two main axes of the RAS cascade. Angiotensin (1-7), an angiotensin converting enzyme 2 and Mas receptor axis (ACE2-Ang(1-7)-MasR) counterbalances the harmful effects of the angiotensin II, angiotensin converting enzyme 1 and angiotensin II type 1 receptor axis (ACE1-AngII-AT1R) Whereas systemic RAS is an important factor in blood pressure regulation, tissue-specific regulatory system, responsible for long term regional changes, that has been found in various organs. In other words, RAS is not only endocrine but also complicated autocrine system. The human eye has its own intraocular RAS that is present e.g. in the structures involved in aqueous humor dynamics. Local RAS may thus be a target in the development of new anti-glaucomatous drugs. In this review, we first describe the systemic RAS cascade and then the local ocular RAS especially in the anterior part of the eye.

Keywords: ACE1; ACE2; Angiotensin (1-7); Angiotensin II; Eye; Glaucoma; Intraocular pressure; Mas receptor; Renin-angiotensin system.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
The renin-angiotensin system. The two main axes of RAS are highlighted with colors. ACE2-Ang(1-7)-MasR axis (red lines) counterbalances the harmful effects of the ACE1-Ang II-AT1R axis (blue lines). ACE1: Angiotensin-converting enzyme 1; ACE2: Angiotensin-converting enzyme related carboxypeptidase; Ang I, II, III, IV: Angiotensin I, II, III, IV; Ang A: Angiotensin A; AT1R, -2R, -4R: Angiotensin II type 1, -2, -4 receptor; AP: Aminopeptidase (-A, -N, -M, -B); B1/B2: Bradykinin receptors; CAGE: Chymostatin-sensitive Ang II generating enzyme; CP: Carboxypeptidase; EP: Endopeptidase; Mas receptor: Ang(1-7) receptor type; NEP: Neprilysin; PEP: Prolyl-endopeptidase; PCP: Prolyl-carboxypeptidase; tPA: Tissue-type plasminogen activator. In angiotensin peptides the numbers in parenthesis refers to the numbers of amino acid residues. The figure is updated from Vaajanen et al. [41].

Similar articles

Cited by

References

    1. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006;90(3):262–267. doi: 10.1136/bjo.2005.081224. - DOI - PMC - PubMed
    1. Leite M.T., Sakata L.M., Medeiros F.A. Managing glaucoma in developing countries. Arq. Bras. Oftalmol. 2011;74(2):83–84. doi: 10.1590/S0004-27492011000200001. - DOI - PMC - PubMed
    1. Rotchford A.P., Kirwan J.F., Muller M.A., Johnson G.J., Roux P. Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. Ophthalmology. 2003;110(2):376–382. doi: 10.1016/S0161-6420(02)01568-3. - DOI - PubMed
    1. Friedman D.S., Wolfs R.C., O’Colmain B.J., Klein B.E., Taylor H.R., West S., Leske M.C., Mitchell P., Congdon N., Kempen J., Eye Diseases Prevalence Research Group Prevalence of open-angle glaucoma among adults in the United States. Arch. Ophthalmol. 2004;122(4):532–538. doi: 10.1001/archopht.122.4.532. - DOI - PMC - PubMed
    1. Day A.C., Baio G., Gazzard G., Bunce C., Azuara-Blanco A., Munoz B., Friedman D.S., Foster P.J. The prevalence of primary angle closure glaucoma in European derived populations: a systematic review. Br. J. Ophthalmol. 2012;96(9):1162–1167. doi: 10.1136/bjophthalmol-2011-301189. - DOI - PubMed